401 related articles for article (PubMed ID: 16397213)
1. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.
Elstrodt F; Hollestelle A; Nagel JH; Gorin M; Wasielewski M; van den Ouweland A; Merajver SD; Ethier SP; Schutte M
Cancer Res; 2006 Jan; 66(1):41-5. PubMed ID: 16397213
[TBL] [Abstract][Full Text] [Related]
2. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
5. Germline BRCA1 mutation and survival analysis in familial breast cancer patients in Kerala; South India.
Vinodkumar B; Syamala V; Abraham EK; Balakrishnan R; Ankathil R
J Exp Clin Cancer Res; 2007 Sep; 26(3):329-36. PubMed ID: 17987791
[TBL] [Abstract][Full Text] [Related]
6. AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines.
Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
Anticancer Res; 2010 Jun; 30(6):2049-54. PubMed ID: 20651350
[TBL] [Abstract][Full Text] [Related]
7. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
8. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M
Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo.
Quaresima B; Romeo F; Faniello MC; Di Sanzo M; Liu CG; Lavecchia A; Taccioli C; Gaudio E; Baudi F; Trapasso F; Croce CM; Cuda G; Costanzo F
Clin Cancer Res; 2008 Nov; 14(21):6797-803. PubMed ID: 18980973
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.
Tomlinson GE; Chen TT; Stastny VA; Virmani AK; Spillman MA; Tonk V; Blum JL; Schneider NR; Wistuba II; Shay JW; Minna JD; Gazdar AF
Cancer Res; 1998 Aug; 58(15):3237-42. PubMed ID: 9699648
[TBL] [Abstract][Full Text] [Related]
11. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair--perhaps through transcription.
Somasundaram K
J Cell Biochem; 2003 Apr; 88(6):1084-91. PubMed ID: 12647291
[TBL] [Abstract][Full Text] [Related]
13. [BRCA1 1100delAT is a recurrent mutation in Chinese women with familial breast cancer].
Li WF; Hu Z; Zhang B; Cao MZ; Wang YS; Liu XY; Zhao L; Liu YB; Yuan WT; Shen ZZ; Huang W; Shao ZM
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):76-80. PubMed ID: 17418009
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
Li WF; Hu Z; Rao NY; Song CG; Zhang B; Cao MZ; Su FX; Wang YS; He PQ; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Liu XY; Zhou J; Wang L; Zhao L; Liu YB; Yuan WT; Yang L; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2008 Jul; 110(1):99-109. PubMed ID: 17851763
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
[TBL] [Abstract][Full Text] [Related]
16. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
17. Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
Konstantopoulou I; Rampias T; Ladopoulou A; Koutsodontis G; Armaou S; Anagnostopoulos T; Nikolopoulos G; Kamakari S; Nounesis G; Stylianakis A; Karanikiotis C; Razis E; Gogas H; Keramopoulos A; Gaki V; Markopoulos C; Skarlos D; Pandis N; Bei T; Arzimanoglou I; Fountzilas G; Yannoukakos D
Breast Cancer Res Treat; 2008 Feb; 107(3):431-41. PubMed ID: 17453335
[TBL] [Abstract][Full Text] [Related]
18. Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus.
Loizidou M; Marcou Y; Anastasiadou V; Newbold R; Hadjisavvas A; Kyriacou K
Clin Genet; 2007 Feb; 71(2):165-70. PubMed ID: 17250666
[TBL] [Abstract][Full Text] [Related]
19. Identification of BAF57 mutations in human breast cancer cell lines.
Kiskinis E; García-Pedrero JM; Villaronga MA; Parker MG; Belandia B
Breast Cancer Res Treat; 2006 Jul; 98(2):191-8. PubMed ID: 16538531
[TBL] [Abstract][Full Text] [Related]
20. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
